These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


259 related items for PubMed ID: 12204701

  • 1. Effects of prostaglandins on the aqueous humor outflow pathways.
    Weinreb RN, Toris CB, Gabelt BT, Lindsey JD, Kaufman PL.
    Surv Ophthalmol; 2002 Aug; 47 Suppl 1():S53-64. PubMed ID: 12204701
    [Abstract] [Full Text] [Related]

  • 2. Advances in glaucoma diagnosis and therapy for the next millennium: new drugs for trabecular and uveoscleral outflow.
    Kaufman PL, Gabelt B, Tian B, Liu X.
    Semin Ophthalmol; 1999 Sep; 14(3):130-43. PubMed ID: 10790577
    [Abstract] [Full Text] [Related]

  • 3. The mechanism of action of prostaglandins on uveoscleral outflow.
    Schachtschabel U, Lindsey JD, Weinreb RN.
    Curr Opin Ophthalmol; 2000 Apr; 11(2):112-5. PubMed ID: 10848216
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Enhancing trabecular outflow by disrupting the actin cytoskeleton, increasing uveoscleral outflow with prostaglandins, and understanding the pathophysiology of presbyopia interrogating Mother Nature: asking why, asking how, recognizing the signs, following the trail.
    Kaufman PL.
    Exp Eye Res; 2008 Jan; 86(1):3-17. PubMed ID: 18053986
    [Abstract] [Full Text] [Related]

  • 6. Topical prostaglandin F2alpha treatment reduces collagen types I, III, and IV in the monkey uveoscleral outflow pathway.
    Sagara T, Gaton DD, Lindsey JD, Gabelt BT, Kaufman PL, Weinreb RN.
    Arch Ophthalmol; 1999 Jun; 117(6):794-801. PubMed ID: 10369592
    [Abstract] [Full Text] [Related]

  • 7. The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
    Nilsson SF, Drecoll E, Lütjen-Drecoll E, Toris CB, Krauss AH, Kharlamb A, Nieves A, Guerra T, Woodward DF.
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):4042-9. PubMed ID: 16936121
    [Abstract] [Full Text] [Related]

  • 8. Prostaglandin action on ciliary smooth muscle extracellular matrix metabolism: implications for uveoscleral outflow.
    Lindsey JD, Kashiwagi K, Kashiwagi F, Weinreb RN.
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S53-9. PubMed ID: 9154277
    [Abstract] [Full Text] [Related]

  • 9. Deconstructing aqueous humor outflow - The last 50 years.
    Kaufman PL.
    Exp Eye Res; 2020 Aug; 197():108105. PubMed ID: 32590004
    [Abstract] [Full Text] [Related]

  • 10. Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.
    Toris CB, Gabelt BT, Kaufman PL.
    Surv Ophthalmol; 2008 Nov; 53 Suppl1(SUPPL1):S107-20. PubMed ID: 19038618
    [Abstract] [Full Text] [Related]

  • 11. Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow.
    Woodward DF, Nilsson SF, Toris CB, Kharlamb AB, Nieves AL, Krauss AH.
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3320-8. PubMed ID: 19234340
    [Abstract] [Full Text] [Related]

  • 12. Effects of exogenous prostaglandins on aqueous humor dynamics and blood-aqueous barrier function.
    Toris CB, Camras CB, Yablonski ME, Brubaker RF.
    Surv Ophthalmol; 1997 Feb; 41 Suppl 2():S69-75. PubMed ID: 9154279
    [Abstract] [Full Text] [Related]

  • 13. Matrix Metalloproteinases and Glaucoma Treatment.
    Weinreb RN, Robinson MR, Dibas M, Stamer WD.
    J Ocul Pharmacol Ther; 2020 May; 36(4):208-228. PubMed ID: 32233938
    [Abstract] [Full Text] [Related]

  • 14. The uveoscleral outflow routes.
    Nilsson SF.
    Eye (Lond); 1997 May; 11 ( Pt 2)():149-54. PubMed ID: 9349404
    [Abstract] [Full Text] [Related]

  • 15. Uveoscleral outflow--a review.
    Alm A, Nilsson SF.
    Exp Eye Res; 2009 Apr; 88(4):760-8. PubMed ID: 19150349
    [Abstract] [Full Text] [Related]

  • 16. Prostaglandin A2 increases uveoscleral outflow and trabecular outflow facility in the cat.
    Toris CB, Yablonski ME, Wang YL, Hayashi M.
    Exp Eye Res; 1995 Dec; 61(6):649-57. PubMed ID: 8846836
    [Abstract] [Full Text] [Related]

  • 17. Effects of bunazosin hydrochloride on ciliary muscle constriction and matrix metalloproteinase activities.
    Akaishi T, Takagi Y, Matsugi T, Ishida N, Hara H, Kashiwagi K.
    J Glaucoma; 2004 Aug; 13(4):312-8. PubMed ID: 15226660
    [Abstract] [Full Text] [Related]

  • 18. Prostaglandin effects on the contractility of bovine trabecular meshwork and ciliary muscle.
    Krauss AH, Wiederholt M, Sturm A, Woodward DF.
    Exp Eye Res; 1997 Mar; 64(3):447-53. PubMed ID: 9196397
    [Abstract] [Full Text] [Related]

  • 19. Advances in glaucoma treatment and management: outflow drugs.
    Kaufman PL, Rasmussen CA.
    Invest Ophthalmol Vis Sci; 2012 May 04; 53(5):2495-500. PubMed ID: 22562850
    [No Abstract] [Full Text] [Related]

  • 20. Effect of latanoprost on the extracellular matrix of the ciliary muscle. A study on cultured cells and tissue sections.
    Ocklind A.
    Exp Eye Res; 1998 Aug 04; 67(2):179-91. PubMed ID: 9733584
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.